Difference between revisions of "User:Wayneliang"
(Created page with "Wayne Liang, MD is the HemOnc.org Section Editor of Pediatric Oncology.") |
Warner-admin (talk | contribs) |
||
| (11 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
| − | Wayne Liang, MD is the HemOnc.org Section Editor of Pediatric Oncology. | + | [[File:Wayne Liang.jpg|alt=|thumb|Wayne Liang, MD MS]] |
| + | Wayne Liang, MD MS FAMIA FAAP is a pediatric hematology/oncology attending physician and physician informaticist at Children's Healthcare of Atlanta, and Assistant Professor of Pediatrics at Emory University, with a clinical focus in pediatric bone marrow transplant. Dr. Liang focuses on clinical informatics for cancer, bone marrow transplant, and genomic precision medicine. He participates as a clinical investigator for childhood cancer clinical trials through the [https://www.childrensoncologygroup.org/ Children's Oncology Group] and other cooperative groups. Dr. Liang is board-certified in Pediatrics, Pediatric Hematology/Oncology, and Clinical Informatics (ABPM). | ||
| + | |||
| + | Dr. Liang was the HemOnc.org Section Editor of [[:Category:Pediatric hematologic neoplasms|Pediatric Leukemia & Lymphoma]] from 2018-2022 and is currently the Associate Editor of [[:Category:Pediatric cancers|Pediatric Hematology/Oncology]]. | ||
| + | ==External Links== | ||
| + | *[https://twitter.com/WayneLiangMD Twitter.com/WayneLiangMD] | ||
| + | *[https://linkedin.com/in/wayneliang LinkedIn] | ||
| + | *[https://www.doximity.com/cv/wayneliang Doximity] | ||
Latest revision as of 00:24, 29 August 2023
Wayne Liang, MD MS FAMIA FAAP is a pediatric hematology/oncology attending physician and physician informaticist at Children's Healthcare of Atlanta, and Assistant Professor of Pediatrics at Emory University, with a clinical focus in pediatric bone marrow transplant. Dr. Liang focuses on clinical informatics for cancer, bone marrow transplant, and genomic precision medicine. He participates as a clinical investigator for childhood cancer clinical trials through the Children's Oncology Group and other cooperative groups. Dr. Liang is board-certified in Pediatrics, Pediatric Hematology/Oncology, and Clinical Informatics (ABPM).
Dr. Liang was the HemOnc.org Section Editor of Pediatric Leukemia & Lymphoma from 2018-2022 and is currently the Associate Editor of Pediatric Hematology/Oncology.